Center competition and outcomes following liver transplantation

Liver Transplantation

Volumn 19, Issue 1, 2013, Pages 96-104

  Halldorson, Jeffrey B ^a   Paarsch, Harry J ^b   Dodge, Jennifer L ^c   Segre, Alberto M ^d   Lai, Jennifer ^c   Roberts, John Paul ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b AMAZON   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University of Iowa   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DEATH; DONOR; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEALTH CARE FACILITY; HUMAN; LIVER; LIVER TRANSPLANTATION; PATIENT SELECTION; PRIORITY JOURNAL; SCORING SYSTEM; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME;

EID: 84871988343     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23561     Document Type: Article

References (10)

1. Freeman RB Jr, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM,. Improving liver allocation: MELD and PELD. Am J Transplant 2004; 4 (suppl 9): 114-131. (Pubitemid 38859000)
2. Scientific Registry of Transplant Recipients. Deceased donor graft survival model description 1 year (and 1 month) after transplant. Organ: liver. Adult (age 18+). Transplants between 07/01/2008 and 12/31/2010. http://srtr.org/csr/current/modtabs.aspx. Accessed October 2012.
3. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: The concept of a donor risk index. Am J Transplant 2006; 6: 783-790. (Pubitemid 43345017)
4. United States Census Bureau. Vintage 2008: national tables. http://www.census.gov/popest/data/historical/2000s/vintage-2008/index.html. Accessed October 2012.
5. Scientific Registry of Transplant Recipients. OPO-specific reports. http://www.srtr.org/opo/Default.aspx. Accessed October 2012.
6. Dutkowski P, Oberkofler CE, Béchir M, Müllhaupt B, Geier A, Raptis DA, Clavien PA,. The Model for End-Stage Liver Disease allocation system for liver transplantation saves lives, but increases morbidity and cost: A prospective outcome analysis. Liver Transpl 2011; 17: 674-684.
7. Åberg F, Mäklin S, Räsänen P, Roine RP, Sintonen H, Koivusalo AM, et al. Cost of a quality-adjusted life year in liver transplantation: The influence of the indication and the Model for End-Stage Liver Disease score. Liver Transpl 2011; 17: 1333-1343.
8. Axelrod DA, Schnitzler M, Salvalaggio PR, Swindle J, Abecassis MM,. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7: 990-997. (Pubitemid 46481202)
9. Salvalaggio PR, Dzebisashvili N, MacLeod KE, Lentine KL, Gheorghian A, Schnitzler MA, et al. The interaction among donor characteristics, severity of liver disease, and the cost of liver transplantation. Liver Transpl 2011; 17: 233-242.
10. Volk ML, Reichert HA, Lok AS, Hayward RA,. Variation in organ quality between liver transplant centers. Am J Transplant 2011; 11: 958-964.